send link to app

VLA1553-302


4.8 ( 6368 ratings )
Medical
Desenvolvedor: Parallel 6, Inc.
Darmowy

Clinical Trial Study App for the Valneva VLA1553-302 Vaccine study. This is a study to demonstrate lot-to-lot consistency of three lots of a live-attenuated Chikungunya virus. the app enables study participants to complete eDiary entries, view scheduled appointments, conduct video consultations, and access resources about the study.